Title:
CRYSTAL FORM OF A3 ADENOSINE RECEPTOR AGONIST DRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2019/105388
Kind Code:
A1
Abstract:
The present invention relates to a new crystal form of compound I and a preparation method therefor, a pharmaceutical composition comprising the crystal form, and a use of the crystal form in preparing an A3 adenosine receptor agonist and a pharmaceutical preparation for treating rheumatic arthritis, psoriasis, osteoarthritis, or glaucoma. The crystal form of compound I provided in the present invention has one or more improved properties compared with the prior art, and has a significant value for medicinal optimization and development.
Inventors:
CHEN MINHUA (CN)
ZHANG YANFENG (CN)
LIU QIYUE (CN)
LUO MIN (CN)
ZHANG XIAOYU (CN)
YANG CHAOHUI (CN)
ZHANG YANFENG (CN)
LIU QIYUE (CN)
LUO MIN (CN)
ZHANG XIAOYU (CN)
YANG CHAOHUI (CN)
Application Number:
PCT/CN2018/117958
Publication Date:
June 06, 2019
Filing Date:
November 28, 2018
Export Citation:
Assignee:
CRYSTAL PHARMACEUTICAL SUZHOU CO LTD (CN)
International Classes:
C07H19/16; A61K31/7076; A61P35/00
Domestic Patent References:
| WO1995002604A1 | 1995-01-26 | |||
| WO2003029264A2 | 2003-04-10 |
Foreign References:
| CN101646685A | 2010-02-10 |
Download PDF:
Previous Patent: TURNOVER MECHANISM
Next Patent: METHOD FOR ALLOCATING A RESOURCE IN A USER EQUIPMENT AND USER EQUIPMENT
Next Patent: METHOD FOR ALLOCATING A RESOURCE IN A USER EQUIPMENT AND USER EQUIPMENT